Myriad Genetics, Inc.
USD5.85
-0.03 (-0.51%)
CEO
Samraat S Raha
IPO Date
1995-10-06
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Open
$5.86
Prev. Close
$5.88
Day Low
$5.78
Day High
$6.04
52W Low
$3.53
52W High
$8.59
Market Cap
$0.55B
Volume
1.93M
| 3,542 |
| $3.94 |
| 12 Jun 2026 | Donnelly Brian J | Chief Commerical Officer | A-Award | Acquired | 5,000 | $3.94 |
| 9 Jun 2026 | Kumar Rashmi | director | S-Sale | Disposed | 15,000 | $4.46 |
| 5 Jun 2026 | Skovronsky Daniel | director | A-Award | Acquired | 59,701 | $0.00 |
| 5 Jun 2026 | Newcomer Lee Nisley | director | A-Award | Acquired | 59,701 | $0.00 |
| 5 Jun 2026 | Davis Mark Steven | director | A-Award | Acquired | 59,701 | $0.00 |
| 5 Jun 2026 | Phanstiel S. Louise | director | A-Award | Acquired | 59,701 | $0.00 |
| 5 Jun 2026 | Dreismann Heinrich | director | A-Award | Acquired | 59,701 | $0.00 |
| 5 Jun 2026 | Reitan Colleen F | director | A-Award | Acquired | 59,701 | $0.00 |